Ferric Carboxymaltose Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg/mL
Reference Brands: Injectafer
Category: Anemia
Ferric Carboxymaltose Injection (Injectafer®/Ferinject®) is an intravenous iron therapy for treating iron deficiency anemia. With a concentration of 50 mg/mL, it allows for large, single-dose infusions. It is widely used in hospitals and clinics across the U.S. and EU. Ferric Carboxymaltose Injection is available in Injection and strengths such as 50 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ferric Carboxymaltose Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Ferric Carboxymaltose Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Ferric Carboxymaltose Injection (brand names Injectafer® in the U.S. and Ferinject® in the EU) is a high-concentration intravenous iron therapy used to treat iron deficiency anemia, particularly in patients who cannot tolerate oral iron or need rapid iron repletion. With a strength of 50 mg/mL, it allows for large, single-dose infusions, enhancing patient convenience and adherence. In the U.S. and EU, Ferric Carboxymaltose is in high demand across hospitals, dialysis centers, and specialty clinics. In the pharmaceutical B2B sector, it is supplied by licensed manufacturers, contract partners, and distributors to meet institutional needs and ensure global availability.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Ferric Carboxymaltose is used to treat iron-deficiency anaemia in patients who cannot tolerate oral iron or need rapid replenishment of iron stores. It helps restore haemoglobin levels and improves symptoms related to low iron.
It is made from a stable iron–carbohydrate complex containing ferric hydroxide tightly bound to a carboxymaltose polymer. This structure allows controlled iron release and efficient absorption.
The main trade name is Injectafer in the US and Ferinject in many international markets.
It is manufactured by Vifor Pharma, and marketed in collaboration with other licensed partners in different countries.
The generic name is Ferric Carboxymaltose.
Brand names include Injectafer and Ferinject.
It is manufactured in multiple Vifor Pharma facilities and approved partner manufacturing sites across Europe and other regions.
Related Products
Epoetin Alfa
Strength:
1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
View Details
Ferumoxytol Injection
Strength:
30 mg/mL
Form: Injection
Reference Brands: Feraheme (USA)
View Details
Deferoxamine
Strength:
500 mg/vial, 2 g/vial
Form: Lyophilized powder for injection
Reference Brands: Desferal
View Details
Deferasirox
Strength:
125 mg, 250 mg, 500 mg
Form: Tablets for Oral Suspension
Reference Brands: Exjade, Jadenu (film-coated)
View DetailsQuick Response Guaranteed | Verified Suppliers
